Effect of Mulligan's Mobilization on Shoulder Joint Range of Motion and Subacromial Space in Paraplegic Patients
Launched by MTI UNIVERSITY · Nov 25, 2024
Trial Information
Current as of July 24, 2025
Completed
Keywords
ClinConnect Summary
30 patients will be randomly assigned to two groups Group (A): will receive Mulligan's mobilization plus steroid injection for rotator cuff tendinopathy Group (B): will receive Steroid injection for rotator cuff tendinopathy only
Outcome measures will be:
* shoulder joint range of motion will be measured by laser goniometer
* Subacromial joint space will be measured by 3D ultrasonography
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • More than one year after traumatic spinal cord injury
- • The injury is at the second thoracic level or below.
- • No cognitive impairment
- • Relying on manual wheelchair for main movement.
- Exclusion Criteria:
- • No frozen shoulder
- • No subluxation
About Mti University
MTI University is a leading academic institution dedicated to advancing healthcare and medical research through innovative clinical trials. Committed to fostering collaboration between academic researchers and industry partners, MTI University focuses on developing cutting-edge therapies and technologies aimed at improving patient outcomes. With a robust infrastructure and a team of experienced professionals, the university prioritizes ethical standards and regulatory compliance in its research endeavors, ensuring the highest quality of care and safety for participants. As a sponsor, MTI University is dedicated to contributing valuable insights to the scientific community and enhancing the overall landscape of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saudi Arabia, , Saudi Arabia
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported